BBIO
Price
$65.06
Change
-$1.16 (-1.75%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
12.54B
97 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$20.56
Change
-$0.76 (-3.56%)
Updated
Nov 13 closing price
Capitalization
14.3B
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BBIO vs ROIV

Header iconBBIO vs ROIV Comparison
Open Charts BBIO vs ROIVBanner chart's image
BridgeBio Pharma
Price$65.06
Change-$1.16 (-1.75%)
Volume$46.69K
Capitalization12.54B
Roivant Sciences
Price$20.56
Change-$0.76 (-3.56%)
Volume$8.08M
Capitalization14.3B
BBIO vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
BBIO vs. ROIV commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a StrongBuy and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BBIO: $65.06 vs. ROIV: $20.56)
Brand notoriety: BBIO and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 75% vs. ROIV: 91%
Market capitalization -- BBIO: $12.54B vs. ROIV: $14.3B
BBIO [@Biotechnology] is valued at $12.54B. ROIV’s [@Biotechnology] market capitalization is $14.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, both BBIO and ROIV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 3 bullish TA indicator(s).

  • BBIO’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both BBIO and ROIV are a good buy in the short-term.

Price Growth

BBIO (@Biotechnology) experienced а +3.71% price change this week, while ROIV (@Biotechnology) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 19, 2026.

ROIV is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($14.3B) has a higher market cap than BBIO($12.5B). BBIO YTD gains are higher at: 141.327 vs. ROIV (80.220). BBIO has higher annual earnings (EBITDA): -643.59M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. BBIO (757M). ROIV has less debt than BBIO: ROIV (99.7M) vs BBIO (1.86B). BBIO has higher revenues than ROIV: BBIO (236M) vs ROIV (23.2M).
BBIOROIVBBIO / ROIV
Capitalization12.5B14.3B87%
EBITDA-643.59M-1.18B55%
Gain YTD141.32780.220176%
P/E RatioN/A1.97-
Revenue236M23.2M1,017%
Total Cash757M4.5B17%
Total Debt1.86B99.7M1,864%
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BBIO
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXU197.0418.53
+10.38%
MicroSectors™ Gold Miners 3X Lvrgd ETN
JETU24.611.09
+4.64%
MAX Airlines 3X Leveraged ETN
CIL53.180.43
+0.81%
VictoryShares International Vol Wtd ETF
GAUG38.87-0.04
-0.11%
FT Vest U.S. Eq Mod Buffr ETF - Aug
QHY46.46-0.09
-0.19%
WisdomTree US Hi Yld Corp Bd

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-0.54%
AXON - BBIO
44%
Loosely correlated
-0.47%
ARRY - BBIO
43%
Loosely correlated
-8.69%
PMN - BBIO
43%
Loosely correlated
+3.95%
XENE - BBIO
42%
Loosely correlated
-0.60%
ROIV - BBIO
40%
Loosely correlated
+2.01%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+2.01%
IMVT - ROIV
60%
Loosely correlated
+2.40%
RVMD - ROIV
52%
Loosely correlated
+2.73%
ACLX - ROIV
50%
Loosely correlated
-0.09%
XENE - ROIV
50%
Loosely correlated
-0.60%
IRON - ROIV
49%
Loosely correlated
-0.06%
More